TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development
Curated by ChEMBL
Roche Pharma Research And Early Development
Curated by ChEMBL
Affinity DataEC50: 0.160nMAssay Description:Inhibition of RSV Long fusion protein assessed as decrease in virus induced syncytium formation in infected human HeLa/M cellsMore data for this Ligand-Target Pair